Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For RJF
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -17.05 3.12 3.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -268.91 -12.98 -3.52
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 1.94 52.73 51.73
Cash 18.80 110.39 92.92
Capex 1.86 -0.24 -0.24
Free Cash Flow -13.26 2.05 2.36
Revenue 21.70 17.35 14.25
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -13.91 0.84 0.98
Operating Margin -72.93 0.18 0.68
ROA -5.71 < 0.005 < 0.005
ROE -6.11 0.04 0.05
ROIC -69.24 0.03 0.11
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of RJF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of RJF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of RJF is permitted for members.